NOTICIAS

Últimas Noticias

ICYMI: Rubio Joins America Reports

U.S. Senator Marco Rubio (R-FL) joined America Reports to discuss President-elect Donald Trump’s historic victory, Democrats’ proclamation of “resistance,” and the failure of identity politics. See below for highlights and watch the full interview on YouTube and...

leer más

Inauguration Ticket Information

Senator Rubio's office is pleased to be issuing a limited number of tickets to President-elect Donald Trump's inauguration ceremony, which will occur on January 20, 2025 at the West Front of the U.S. Capitol. Floridians interested in receiving tickets should fill out...

leer más

ICYMI: Rubio Joins Hannity

U.S. Senator Marco Rubio (R-FL) joined Hannity to discuss President-elect Donald Trump’s historic victory. See below for highlights and watch the full interview on YouTube and Rumble. On the ongoing realignment among American voters: “The Republican Party now reflects...

leer más

National Ovarian Cancer Awareness Month

Sep 12, 2012 | Blog

Senator Rubio marked National Ovarian Cancer Awareness Month submitting the following Statement for the Record:

Mr. President, I rise today to express support for women across America who are battling ovarian cancer and their families and friends who stand with them in their fight. It is estimated 22,280 women will be diagnosed with ovarian cancer this year. Of these women, 15,500 of them will lose the battle against this disease – 1,040 of the women who will lose the battle this year live in Florida. To put those numbers in perspective, this year, across America, three percent of new cancer diagnoses in women will be ovarian cancer, but ovarian cancer will account for six percent of female cancer deaths this year.

September marks National Ovarian Cancer Awareness Month, which is why I chose now to bring attention to this disease. Ovarian cancer is the ninth most common cancer in women and the fifth leading cause of cancer-related deaths because ovarian cancer is a unique cancer – there are no screening tests or early detection tests available. However, if ovarian cancer is treated before it has spread past the ovary, the five-year survival rate is 93 percent. Sadly, only 15 percent of ovarian cancer diagnoses happen in this early stage, making the overall five-year survival a mere 46 percent.

Until a screening test is developed, the best we can do to protect our wives, daughters, sisters, nieces, mothers, grandmothers, aunts, and friends is to bring awareness to the risk factors, signs, and symptoms of ovarian cancer. I urge my colleagues to help educate women about the potential warning signs to help with early diagnosis, which is the best method to save lives.